Index of medicine substances

Lenvatinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX08)

Lepirudin  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Direct thrombin inhibitors (B01AE02)

Lercanidipine  •  Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives (C08CA13)

Letermovir  •  Antiinfectives for systemic use | Direct acting antivirals | Other antivirals (J05AX18)

Letrozole  •  Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Aromatase inhibitors (L02BG04)

Leuprorelin  •  Antineoplastic and immunomodulating agents | Hormones and related agents | Gonadotropin releasing hormone analogues (L02AE02)

Levamisole  •  Antiparasitic products, insecticides and repellents | Antinematodal agents | Imidazothiazole derivatives (P02CE01)

Levetiracetam  •  Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics (N03AX14)

Levobupivacaine  •  Nervous system | Anesthetics | Anesthetics, local | Amides (N01BB10)

Levocabastine  •  Sensory organs | Decongestants and antiallergics | Other antiallergics (S01GX02)

Levocarnitine  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Amino acids and derivatives (A16AA01)

Levocetirizine  •  Respiratory system | Antihistamines for systemic use | Antihistamines for systemic use | Piperazine derivatives (R06AE09)

Levodopa + benserazide  •  Nervous system | Dopaminergic agents | Dopa and dopa derivatives (N04BA02)

Levodopa + carbidopa  •  Nervous system | Dopaminergic agents | Dopa and dopa derivatives (N04BA02)

Levodopa + carbidopa + entacapone  •  Nervous system | Dopaminergic agents | Dopa and dopa derivatives (N04BA03)

Levodropropysin  •  Respiratory system | Cough suppressants, excl. combinations with expectorants | Other cough suppressants (R05DB27)

Levofloxacin  •  Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones (J01MA12)

Levomepromazine  •  Nervous system | Antipsychotics | Phenothiazines with aliphatic side-chain (N05AA02)

Levomethadone  •  Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence (N07BC02)

Levomethamphetamine  •  Respiratory system | Decongestants and other nasal preparations for topical use | Other nasal preparations (R01AX10)

Levonorgestrel  •  Genito urinary system and sex hormones | Contraceptives for topical use | Intrauterine contraceptives (G02BA03)

Levonorgestrel + ethinylestradiol  •  Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations (G03AA07)

Levosimendan  •  Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Other cardiac stimulants (C01CX08)

Levosulpiride  •  Nervous system | Antipsychotics | Benzamides (N05AL07)

Levothyroxine  •  Systemic hormonal preparations, excluding sex hormones and insulins | Thyroid preparations | Thyroid hormones (H03AA01)

Levothyroxine + liothyronine  •  Systemic hormonal preparations, excluding sex hormones and insulins | Thyroid preparations | Thyroid hormones (H03AA03)

Levothyroxine + potassium iodide  •  Systemic hormonal preparations, excluding sex hormones and insulins | Thyroid preparations | Thyroid hormones (H03AAN1)

Lidocaine  •  Nervous system | Anesthetics | Anesthetics, local | Amides (N01BB02)

Lidocaine + adrenaline  •  Nervous system | Anesthetics | Anesthetics, local | Amides (N01BB52)

Lidocaine + amylmetacresol + dichlorobenzyl alcohol  •  Respiratory system | Throat preparations | Throat preparations | Antiseptics (R02AA03)